Subcutaneous G-CSF treatment in ALS patients appears as feasible approach.Although exploratory analysis of clinical data showed no significant effect,DTI measurements suggest that the widespread and progressive microstructuralneural damage in ALS can be modulated by G-CSF treatment. Here, CSF3 is linked to amyotrophic lateral sclerosis.